AVROBIO
AVROBIO develops and commercializes step-change cell and gene therapies for the treatment of cancer and rare diseases.
Business Model:
Revenue: $1.2M
Employees: 51-200
Rankings
Industries / Tags:
Detailed AVROBIO Information
Geographic Data
Address: One Kendall Square
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
series b
Raised Last:
$60M
Raised Total:$85M
Social
Metrics
1,870,812Website Global Rank
11,756Website Monthly Traffic
Twitter Followers
Description
AVROBIO develops and commercializes step-change cell and gene therapies for the treatment of cancer and rare diseases.
Contact Phone:
+16179148420
Contact Email:
AVROBIO went public on 6/20/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/20/2018
IPO Valuation:
$440M
Ticker Symbol:
AVRO
IPO Price:
$19/share
Amount Raised:
$100M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
